EyePoint, Inc.

By person

24 insiders · 117 transactions

1.3×

Jay Duker holds only 1.3 times base salary in stock. $922.03K of shares against $696.25K in salary for 2025.

Salary from the company's own proxy. The shares are what Jay Duker last reported holding, valued at $4.93, the price Common Stock was last bought or sold at on the open market here, on 18 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Cormorant Asset Management, LP entity

Former 10% Owner

$89.50M (24)

$942.24K (1)

+$88.55M

8,265,000

9.59%

$40.75M

+134.1%

Liu Ye

Director

—

$56.67M (4)

−$56.67M

100,221

0.1162%

$494.09K

−96.7%

Ocumension Therapeutics

Director

—

$56.67M (3)

−$56.67M

100,221

0.1162%

$494.09K

−96.7%

EW Healthcare Partners, L.P. entity

10% owner

$30.80M (4)

$8.56M (13)

+$22.24M

54,431,701

63.14%

$268.35M

+83.5%

Paggiarino Dario A.

Chief Medical Officer

—

$2.88M (12) scheduled

−$2.88M

67,080

0.0778%

$330.70K

—

Jones David Scott

SVP & Chief Commercial Officer

—

$1.76M (11) scheduled

−$1.76M

44,916

0.0521%

$221.44K

—

Lurker Nancy

Director

$279.24K (4)

$1.64M (7) scheduled

−$1.36M

421,235

0.4886%

$2.08M

—

Pine Michael Craig

Chief Corp Dev.&Strat. Officer

$12.21K (1)

$990.00K (1) scheduled

−$977.79K

13,662

0.0158%

$67.35K

+308.7%

Ribeiro Ramiro

Chief Medical Officer

—

$948.77K (7) scheduled

−$948.77K

0.0000%

$0.00

−100.0%

GUYER DAVID R

Director

—

$383.74K (3) scheduled

−$383.74K

1,850

0.0021%

$9.12K

—

Zaderej Karen L.

Director

$265.46K (6)

—

+$265.46K

49,100

0.0570%

$242.06K

—

Landis John B.

Director

$69.60K (1)

—

+$69.60K

21,400

0.0248%

$105.50K

—

ANDO GORAN

Director

$39.75K (1)

—

+$39.75K

13,150

0.0153%

$64.83K

—

Elston George

Chief Financial Officer

$34.80K (4)

—

+$34.80K

97,470

0.1131%

$480.53K

—

Godshall Douglas Evan

Director

$29.78K (1)

—

+$29.78K

8,016

0.0093%

$39.52K

—

Duker Jay S.

President and CEO

$29.17K (2)

—

+$29.17K

187,025

0.2169%

$922.03K

+390.2%

DICICCO WENDY F

Director

$20.00K (1)

—

+$20.00K

9,967

0.0116%

$49.14K

—

Eastman Ronald W

Director

—

8,606,324

9.98%

$42.43M

0.0%

Mazzo David J

Director

—

200,083

0.2321%

$986.41K

+39,917%

ROGERS MICHAEL W

Director

—

119,167

0.1382%

$587.49K

—

Ross Leonard S

See Remarks

—

90,044

0.1044%

$443.92K

—

Barry James J

Director

—

12,500

0.0145%

$61.63K

—

Peterson Kristine

Director

—

6,667

0.0077%

$32.87K

—

ADAMIS ANTHONY P

Director

—

4,000

0.0046%

$19.72K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Ribeiro Ramiro

30 Jun 2026

Chief Medical Officer

Sold after exercise

2,438

$15.02

$36.61K

Ribeiro Ramiro

30 Jun 2026

Chief Medical Officer

Sold after exercise

2,437

$15.00

$36.56K

Ribeiro Ramiro

17 Apr 2026

Chief Medical Officer

Sold after exercise

2,437

$15.00

$36.56K

Ribeiro Ramiro

4 Mar 2026

Chief Medical Officer

Sold after exercise

2,438

$17.87

$43.57K

Ribeiro Ramiro

17 Feb 2026

Chief Medical Officer

Sold after exercise

2,437

$15.00

$36.56K

Ribeiro Ramiro

5 Jan 2026

Chief Medical Officer

Sold after exercise

42,544

$17.10

$727.32K

GUYER DAVID R

12 Jul 2024

Director

Sold after exercise

11,625

$10.06

$117.00K

GUYER DAVID R

3 Jun 2024

Director

Sold after exercise

11,625

$10.30

$119.70K

GUYER DAVID R

14 May 2024

Director

Sold after exercise

11,625

$12.65

$147.04K

Jones David Scott

2 Feb 2024

SVP & Chief Commercial Officer

Sold after exercise

209

$28.49

$5.95K

Jones David Scott

26 Jan 2024

SVP & Chief Commercial Officer

Sold after exercise

9,604

$25.27

$242.72K

Jones David Scott

26 Jan 2024

SVP & Chief Commercial Officer

Sold after exercise

16,413

$25.45

$417.65K

Paggiarino Dario A.

26 Jan 2024

Chief Medical Officer

Sold after exercise

33,665

$25.77

$867.67K

Paggiarino Dario A.

26 Jan 2024

Chief Medical Officer

Sold after exercise

15,609

$25.41

$396.57K

Paggiarino Dario A.

26 Jan 2024

Chief Medical Officer

Sold after exercise

$25.41

$1.30K

Jones David Scott

25 Jan 2024

SVP & Chief Commercial Officer

Sold after exercise

300

$25.00

$7.50K

Jones David Scott

25 Jan 2024

SVP & Chief Commercial Officer

Sold after exercise

300

$25.00

$7.50K

Paggiarino Dario A.

25 Jan 2024

Chief Medical Officer

Sold after exercise

300

$25.00

$7.50K

Paggiarino Dario A.

25 Jan 2024

Chief Medical Officer

Sold after exercise

300

$25.00

$7.50K

Paggiarino Dario A.

24 Jan 2024

Chief Medical Officer

Sold after exercise

5,651

$25.02

$141.36K

Paggiarino Dario A.

24 Jan 2024

Chief Medical Officer

Sold after exercise

5,600

$25.01

$140.05K

Jones David Scott

24 Jan 2024

SVP & Chief Commercial Officer

Sold after exercise

5,600

$25.01

$140.07K

Jones David Scott

24 Jan 2024

SVP & Chief Commercial Officer

Sold after exercise

5,700

$25.01

$142.55K

Jones David Scott

23 Jan 2024

SVP & Chief Commercial Officer

Sold after exercise

500

$25.00

$12.50K

Jones David Scott

23 Jan 2024

SVP & Chief Commercial Officer

Sold after exercise

400

$25.00

$10.00K

Paggiarino Dario A.

23 Jan 2024

Chief Medical Officer

Sold after exercise

3,096

$25.00

$77.40K

Paggiarino Dario A.

23 Jan 2024

Chief Medical Officer

Sold after exercise

2,039

$25.00

$50.98K

Jones David Scott

22 Jan 2024

SVP & Chief Commercial Officer

Sold after exercise

28,750

$22.69

$652.25K

Jones David Scott

22 Jan 2024

SVP & Chief Commercial Officer

Sold after exercise

5,416

$22.24

$120.44K

Paggiarino Dario A.

8 Jan 2024

Chief Medical Officer

Sold after exercise

22,913

$21.13

$484.12K

Paggiarino Dario A.

13 Dec 2023

Chief Medical Officer

Sold after exercise

1,458

$20.00

$29.16K

Paggiarino Dario A.

4 Dec 2023

Chief Medical Officer

Sold after exercise

30,625

$22.00

$673.75K

Pine Michael Craig

4 Dec 2023

Chief Corp Dev.&Strat. Officer

Sold after exercise

45,000

$22.00

$990.00K

Show all 117 transactions →

By person

Individual transactions

What was left out